Skip to main content
NCBI home page
Canadian Family Physician logoLink to Canadian Family Physician
. 2002 May;48:896–904.

Bipolar spectrum disorders. New perspectives.

Andre Piver 1, Lakshmi N Yatham 1, Raymond W Lam 1
PMCID: PMC2214054  PMID: 12053634

Abstract

OBJECTIVE: To review new perspectives on diagnosis, clinical features, epidemiology, and treatment of bipolar II and related disorders. QUALITY OF EVIDENCE: Articles were identified by searching MEDLINE and ClinPSYCH from January 1994 to August 2001 using the key words bipolar disorder, type II or 2; hypomania; spectrum; or variants. Reference lists from articles were reviewed. Overall, the quality of evidence was not high; we found no randomized controlled trials that specifically addressed bipolar II or bipolar spectrum disorders (BSDs). MAIN MESSAGE: Characterized by elevated mood cycling with depression, BSDs appear to be much more common than previously thought, affecting up to 30% of primary care patients presenting with anxiety or depressive symptoms. Hypomania, the defining feature of bipolar II disorder, is often not detected. Collateral information, semistructured interviews, and brief screening instruments could improve diagnosis. Antidepressants should be used with caution. The newer mood stabilizers or combinations of mood stabilizers might be the treatments of choice in the future. CONCLUSION: Family physicians, as primary providers of mental health care, should try to recognize and treat BSDs more frequently. These disorders are becoming increasingly common in primary care populations.

Full Text

The Full Text of this article is available as a PDF (238.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Akiskal H. S., Maser J. D., Zeller P. J., Endicott J., Coryell W., Keller M., Warshaw M., Clayton P., Goodwin F. Switching from 'unipolar' to bipolar II. An 11-year prospective study of clinical and temperamental predictors in 559 patients. Arch Gen Psychiatry. 1995 Feb;52(2):114–123. doi: 10.1001/archpsyc.1995.03950140032004. [DOI] [PubMed] [Google Scholar]
  2. Akiskal H. S., Pinto O. The evolving bipolar spectrum. Prototypes I, II, III, and IV. Psychiatr Clin North Am. 1999 Sep;22(3):517-34, vii. doi: 10.1016/s0193-953x(05)70093-9. [DOI] [PubMed] [Google Scholar]
  3. Amsterdam J. D., Garcia-España F., Fawcett J., Quitkin F. M., Reimherr F. W., Rosenbaum J. F., Schweizer E., Beasley C. Efficacy and safety of fluoxetine in treating bipolar II major depressive episode. J Clin Psychopharmacol. 1998 Dec;18(6):435–440. doi: 10.1097/00004714-199812000-00003. [DOI] [PubMed] [Google Scholar]
  4. Amsterdam J. Efficacy and safety of venlafaxine in the treatment of bipolar II major depressive episode. J Clin Psychopharmacol. 1998 Oct;18(5):414–417. doi: 10.1097/00004714-199810000-00010. [DOI] [PubMed] [Google Scholar]
  5. Angst J. Major depression in 1998: are we providing optimal therapy? J Clin Psychiatry. 1999;60 (Suppl 6):5–9. [PubMed] [Google Scholar]
  6. Angst J. The emerging epidemiology of hypomania and bipolar II disorder. J Affect Disord. 1998 Sep;50(2-3):143–151. doi: 10.1016/s0165-0327(98)00142-6. [DOI] [PubMed] [Google Scholar]
  7. Bauer M. S., Callahan A. M., Jampala C., Petty F., Sajatovic M., Schaefer V., Wittlin B., Powell B. J. Clinical practice guidelines for bipolar disorder from the Department of Veterans Affairs. J Clin Psychiatry. 1999 Jan;60(1):9–21. doi: 10.4088/jcp.v60n0104. [DOI] [PubMed] [Google Scholar]
  8. Benazzi F. Prevalence of bipolar II disorder in atypical depression. Eur Arch Psychiatry Clin Neurosci. 1999;249(2):62–65. doi: 10.1007/s004060050067. [DOI] [PubMed] [Google Scholar]
  9. Benazzi F. Prevalence of bipolar II disorder in outpatient depression: a 203-case study in private practice. J Affect Disord. 1997 Apr;43(2):163–166. doi: 10.1016/s0165-0327(96)01421-8. [DOI] [PubMed] [Google Scholar]
  10. Calabrese J. R., Bowden C. L., McElroy S. L., Cookson J., Andersen J., Keck P. E., Jr, Rhodes L., Bolden-Watson C., Zhou J., Ascher J. A. Spectrum of activity of lamotrigine in treatment-refractory bipolar disorder. Am J Psychiatry. 1999 Jul;156(7):1019–1023. doi: 10.1176/ajp.156.7.1019. [DOI] [PubMed] [Google Scholar]
  11. Calabrese J. R., Shelton M. D., Bowden C. L., Rapport D. J., Suppes T., Shirley E. R., Kimmel S. E., Caban S. J. Bipolar rapid cycling: focus on depression as its hallmark. J Clin Psychiatry. 2001;62 (Suppl 14):34–41. [PubMed] [Google Scholar]
  12. Calabrese J. R., Suppes T., Bowden C. L., Sachs G. S., Swann A. C., McElroy S. L., Kusumakar V., Ascher J. A., Earl N. L., Greene P. L. A double-blind, placebo-controlled, prophylaxis study of lamotrigine in rapid-cycling bipolar disorder. Lamictal 614 Study Group. J Clin Psychiatry. 2000 Nov;61(11):841–850. doi: 10.4088/jcp.v61n1106. [DOI] [PubMed] [Google Scholar]
  13. Cassano G. B., Akiskal H. S., Savino M., Musetti L., Perugi G. Proposed subtypes of bipolar II and related disorders: with hypomanic episodes (or cyclothymia) and with hyperthymic temperament. J Affect Disord. 1992 Oct;26(2):127–140. doi: 10.1016/0165-0327(92)90044-7. [DOI] [PubMed] [Google Scholar]
  14. Cassano G. B., Dell'Osso L., Frank E., Miniati M., Fagiolini A., Shear K., Pini S., Maser J. The bipolar spectrum: a clinical reality in search of diagnostic criteria and an assessment methodology. J Affect Disord. 1999 Aug;54(3):319–328. doi: 10.1016/s0165-0327(98)00158-x. [DOI] [PubMed] [Google Scholar]
  15. Coryell W., Endicott J., Keller M. Rapidly cycling affective disorder. Demographics, diagnosis, family history, and course. Arch Gen Psychiatry. 1992 Feb;49(2):126–131. doi: 10.1001/archpsyc.1992.01820020046006. [DOI] [PubMed] [Google Scholar]
  16. Fava M., Amsterdam J. D., Deltito J. A., Salzman C., Schwaller M., Dunner D. L. A double-blind study of paroxetine, fluoxetine, and placebo in outpatients with major depression. Ann Clin Psychiatry. 1998 Dec;10(4):145–150. doi: 10.1023/a:1022337927842. [DOI] [PubMed] [Google Scholar]
  17. Frances A. J., Kahn D. A., Carpenter D., Docherty J. P., Donovan S. L. The Expert Consensus Guidelines for treating depression in bipolar disorder. J Clin Psychiatry. 1998;59 (Suppl 4):73–79. [PubMed] [Google Scholar]
  18. Frank E., Swartz H. A., Kupfer D. J. Interpersonal and social rhythm therapy: managing the chaos of bipolar disorder. Biol Psychiatry. 2000 Sep 15;48(6):593–604. doi: 10.1016/s0006-3223(00)00969-0. [DOI] [PubMed] [Google Scholar]
  19. Gardner E. A. Long-term preventive care in depression: the use of bupropion in patients intolerant of other antidepressants. J Clin Psychiatry. 1983 May;44(5 Pt 2):157–162. [PubMed] [Google Scholar]
  20. Ghaemi S. N., Goodwin F. K. Gabapentin treatment of the non-refractory bipolar spectrum: an open case series. J Affect Disord. 2001 Jul;65(2):167–171. doi: 10.1016/s0165-0327(00)00218-4. [DOI] [PubMed] [Google Scholar]
  21. Ghaemi S. N., Katzow J. J., Desai S. P., Goodwin F. K. Gabapentin treatment of mood disorders: a preliminary study. J Clin Psychiatry. 1998 Aug;59(8):426–429. doi: 10.4088/jcp.v59n0805. [DOI] [PubMed] [Google Scholar]
  22. Ghaemi S. N., Sachs G. S., Chiou A. M., Pandurangi A. K., Goodwin K. Is bipolar disorder still underdiagnosed? Are antidepressants overutilized? J Affect Disord. 1999 Jan-Mar;52(1-3):135–144. doi: 10.1016/s0165-0327(98)00076-7. [DOI] [PubMed] [Google Scholar]
  23. Ghaemi S. Nassir, Ko James Y., Goodwin Frederick K. "Cade's disease" and beyond: misdiagnosis, antidepressant use, and a proposed definition for bipolar spectrum disorder. Can J Psychiatry. 2002 Mar;47(2):125–134. doi: 10.1177/070674370204700202. [DOI] [PubMed] [Google Scholar]
  24. Glick I. D., Murray S. R., Vasudevan P., Marder S. R., Hu R. J. Treatment with atypical antipsychotics: new indications and new populations. J Psychiatr Res. 2001 May-Jun;35(3):187–191. doi: 10.1016/s0022-3956(01)00020-6. [DOI] [PubMed] [Google Scholar]
  25. Greil W., Kleindienst N. Lithium versus carbamazepine in the maintenance treatment of bipolar II disorder and bipolar disorder not otherwise specified. Int Clin Psychopharmacol. 1999 Sep;14(5):283–285. [PubMed] [Google Scholar]
  26. Hantouche E. G., Akiskal H. S., Lancrenon S., Allilaire J. F., Sechter D., Azorin J. M., Bourgeois M., Fraud J. P., Châtenet-Duchêne L. Systematic clinical methodology for validating bipolar-II disorder: data in mid-stream from a French national multi-site study (EPIDEP). J Affect Disord. 1998 Sep;50(2-3):163–173. doi: 10.1016/s0165-0327(98)00112-8. [DOI] [PubMed] [Google Scholar]
  27. Himmelhoch J. M., Thase M. E., Mallinger A. G., Houck P. Tranylcypromine versus imipramine in anergic bipolar depression. Am J Psychiatry. 1991 Jul;148(7):910–916. doi: 10.1176/ajp.148.7.910. [DOI] [PubMed] [Google Scholar]
  28. Hirschfeld R. M., Williams J. B., Spitzer R. L., Calabrese J. R., Flynn L., Keck P. E., Jr, Lewis L., McElroy S. L., Post R. M., Rapport D. J. Development and validation of a screening instrument for bipolar spectrum disorder: the Mood Disorder Questionnaire. Am J Psychiatry. 2000 Nov;157(11):1873–1875. doi: 10.1176/appi.ajp.157.11.1873. [DOI] [PubMed] [Google Scholar]
  29. Huxley N. A., Parikh S. V., Baldessarini R. J. Effectiveness of psychosocial treatments in bipolar disorder: state of the evidence. Harv Rev Psychiatry. 2000 Sep;8(3):126–140. [PubMed] [Google Scholar]
  30. Jacobsen F. M. Low-dose valproate: a new treatment for cyclothymia, mild rapid cycling disorders, and premenstrual syndrome. J Clin Psychiatry. 1993 Jun;54(6):229–234. [PubMed] [Google Scholar]
  31. Jarrett R. B., Schaffer M., McIntire D., Witt-Browder A., Kraft D., Risser R. C. Treatment of atypical depression with cognitive therapy or phenelzine: a double-blind, placebo-controlled trial. Arch Gen Psychiatry. 1999 May;56(5):431–437. doi: 10.1001/archpsyc.56.5.431. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Kennedy S. H., Lam R. W., Cohen N. L., Ravindran A. V., CANMAT Depression Work Group Clinical guidelines for the treatment of depressive disorders. IV. Medications and other biological treatments. Can J Psychiatry. 2001 Jun;46 (Suppl 1):38S–58S. [PubMed] [Google Scholar]
  33. Kilzieh N., Akiskal H. S. Rapid-cycling bipolar disorder. An overview of research and clinical experience. Psychiatr Clin North Am. 1999 Sep;22(3):585–607. doi: 10.1016/s0193-953x(05)70097-6. [DOI] [PubMed] [Google Scholar]
  34. Knoll J., Stegman K., Suppes T. Clinical experience using gabapentin adjunctively in patients with a history of mania or hypomania. J Affect Disord. 1998 Jun;49(3):229–233. doi: 10.1016/s0165-0327(98)00027-5. [DOI] [PubMed] [Google Scholar]
  35. Kusumakar V., Yatham L. N., Haslam D. R., Parikh S. V., Matte R., Silverstone P. H., Sharma V. Treatment of mania, mixed state, and rapid cycling. Can J Psychiatry. 1997 Aug;42 (Suppl 2):79S–86S. [PubMed] [Google Scholar]
  36. Lam R. W., Stewart J. N. The validity of atypical depression in DSM-IV. Compr Psychiatry. 1996 Nov-Dec;37(6):375–383. doi: 10.1016/s0010-440x(96)90020-6. [DOI] [PubMed] [Google Scholar]
  37. Lesage A. D., Goering P., Lin E. Family physicians and the mental health system. Report from the Mental Health Supplement to the Ontario Health Survey. Can Fam Physician. 1997 Feb;43:251–256. [PMC free article] [PubMed] [Google Scholar]
  38. Manning J. S., Haykal R. F., Akiskal H. S. The role of bipolarity in depression in the family practice setting. Psychiatr Clin North Am. 1999 Sep;22(3):689-703, x. doi: 10.1016/s0193-953x(05)70103-9. [DOI] [PubMed] [Google Scholar]
  39. Manning J. S., Haykal R. F., Connor P. D., Akiskal H. S. On the nature of depressive and anxious states in a family practice setting: the high prevalence of bipolar II and related disorders in a cohort followed longitudinally. Compr Psychiatry. 1997 Mar-Apr;38(2):102–108. doi: 10.1016/s0010-440x(97)90089-4. [DOI] [PubMed] [Google Scholar]
  40. Marneros A. Expanding the group of bipolar disorders. J Affect Disord. 2001 Jan;62(1-2):39–44. doi: 10.1016/s0165-0327(00)00349-9. [DOI] [PubMed] [Google Scholar]
  41. Möller H. J., Grunze H. Have some guidelines for the treatment of acute bipolar depression gone too far in the restriction of antidepressants? Eur Arch Psychiatry Clin Neurosci. 2000;250(2):57–68. doi: 10.1007/s004060070035. [DOI] [PubMed] [Google Scholar]
  42. Nemeroff C. B. An ever-increasing pharmacopoeia for the management of patients with bipolar disorder. J Clin Psychiatry. 2000;61(Suppl 13):19–25. [PubMed] [Google Scholar]
  43. Perugi G., Akiskal H. S., Lattanzi L., Cecconi D., Mastrocinque C., Patronelli A., Vignoli S., Bemi E. The high prevalence of "soft" bipolar (II) features in atypical depression. Compr Psychiatry. 1998 Mar-Apr;39(2):63–71. doi: 10.1016/s0010-440x(98)90080-3. [DOI] [PubMed] [Google Scholar]
  44. Perugi G., Akiskal H. S., Pfanner C., Presta S., Gemignani A., Milanfranchi A., Lensi P., Ravagli S., Cassano G. B. The clinical impact of bipolar and unipolar affective comorbidity on obsessive-compulsive disorder. J Affect Disord. 1997 Oct;46(1):15–23. doi: 10.1016/s0165-0327(97)00075-x. [DOI] [PubMed] [Google Scholar]
  45. Perugi G., Akiskal H. S., Ramacciotti S., Nassini S., Toni C., Milanfranchi A., Musetti L. Depressive comorbidity of panic, social phobic, and obsessive-compulsive disorders re-examined: is there a bipolar II connection? J Psychiatr Res. 1999 Jan-Feb;33(1):53–61. doi: 10.1016/s0022-3956(98)00044-2. [DOI] [PubMed] [Google Scholar]
  46. Sachs G. S., Printz D. J., Kahn D. A., Carpenter D., Docherty J. P. The Expert Consensus Guideline Series: Medication Treatment of Bipolar Disorder 2000. Postgrad Med. 2000 Apr;Spec No:1–104. [PubMed] [Google Scholar]
  47. Sachs G. S. Use of clonazepam for bipolar affective disorder. J Clin Psychiatry. 1990 May;51 (Suppl):31–53. [PubMed] [Google Scholar]
  48. Sharma V., Yatham L. N., Haslam D. R., Silverstone P. H., Parikh S. V., Matte R., Kutcher S. P., Kusumakar V. Continuation and prophylactic treatment of bipolar disorder. Can J Psychiatry. 1997 Aug;42 (Suppl 2):92S–100S. [PubMed] [Google Scholar]
  49. Simon G. E., Unützer J. Health care utilization and costs among patients treated for bipolar disorder in an insured population. Psychiatr Serv. 1999 Oct;50(10):1303–1308. doi: 10.1176/ps.50.10.1303. [DOI] [PubMed] [Google Scholar]
  50. Simpson S. G., DePaulo J. R. Fluoxetine treatment of bipolar II depression. J Clin Psychopharmacol. 1991 Feb;11(1):52–54. [PubMed] [Google Scholar]
  51. Thase M. E., Sachs G. S. Bipolar depression: pharmacotherapy and related therapeutic strategies. Biol Psychiatry. 2000 Sep 15;48(6):558–572. doi: 10.1016/s0006-3223(00)00980-x. [DOI] [PubMed] [Google Scholar]
  52. Tondo L., Baldessarini R. J., Hennen J., Floris G. Lithium maintenance treatment of depression and mania in bipolar I and bipolar II disorders. Am J Psychiatry. 1998 May;155(5):638–645. doi: 10.1176/ajp.155.5.638. [DOI] [PubMed] [Google Scholar]
  53. Vieta E., Colom F., Martínez-Arán A., Benabarre A., Gastó C. Personality disorders in bipolar II patients. J Nerv Ment Dis. 1999 Apr;187(4):245–248. doi: 10.1097/00005053-199904000-00009. [DOI] [PubMed] [Google Scholar]
  54. Vieta E., Colom F., Martínez-Arán A., Benabarre A., Reinares M., Gastó C. Bipolar II disorder and comorbidity. Compr Psychiatry. 2000 Sep-Oct;41(5):339–343. doi: 10.1053/comp.2000.9011. [DOI] [PubMed] [Google Scholar]
  55. Wehr T. A. Can antidepressants induce rapid cycling? Arch Gen Psychiatry. 1993 Jun;50(6):495–498. doi: 10.1001/archpsyc.1993.01820180097011. [DOI] [PubMed] [Google Scholar]
  56. Weissman M. M., Bland R. C., Canino G. J., Faravelli C., Greenwald S., Hwu H. G., Joyce P. R., Karam E. G., Lee C. K., Lellouch J. Cross-national epidemiology of major depression and bipolar disorder. JAMA. 1996 Jul 24;276(4):293–299. [PubMed] [Google Scholar]
  57. Yatham L. N., Kusumakar V., Parikh S. V., Haslam D. R., Matte R., Sharma V., Kennedy S. Bipolar depression: treatment options. Can J Psychiatry. 1997 Aug;42 (Suppl 2):87S–91S. [PubMed] [Google Scholar]
  58. Young L. T., Robb J. C., Patelis-Siotis I., MacDonald C., Joffe R. T. Acute treatment of bipolar depression with gabapentin. Biol Psychiatry. 1997 Nov 1;42(9):851–853. doi: 10.1016/s0006-3223(97)00305-3. [DOI] [PubMed] [Google Scholar]

Articles from Canadian Family Physician are provided here courtesy of College of Family Physicians of Canada

RESOURCES